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CWH8/YGR036c of Saccharomyces cerevisiae has been
identified as a dolichylpyrophosphate (Dol-PP) phosphatase
that removes a phosphate from the Dol-PP generated by the
oligosaccharyltransferase (OST), while it adds N-glycans to
nascent glycoproteins in the endoplasmic reticulum (ER). Lack
of CWH8 was proposed to interrupt the so called dolichol
(Dol) cycle by trapping Dol in the form of Dol-PP in the ER
lumen. Indeed, cwh8 mutants display a severe deficiency in
N-glycosylation. We find that cwh8 mutants have strongly
reduced levels of inositolphosphorylceramide (IPC), whereas
its derivative, mannosyl-(inositol-P)2-ceramide (M(IP)2C) is
not affected. Microsomes of cwh8 contain normal ceramide
synthase and IPC synthesis activities. Within a large panel of
mutants affecting Dol dependent pathways such as N- or O-
glycosylation, or glycosylphosphatidyl inositol (GPI)-anchor-
ing, only the mutants having a deficiency of N-glycan addi-
tion show the defect in IPC biosynthesis. By mutating genes
required for the addition of N-glycans or by treating cells
with tunicamycin (Tm) one can similarly reduce the steady
state level of IPC and exactly reproduce the phenotype of
cwh8 cells. Some potential mechanisms by which the lack of
N-glycans could lead to the sphingolipid abnormality were
further explored.
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Introduction
Mutants in CWH8/YGR036c were obtained in a screen for
calcofluor white hypersensitivity and were shown to have
an altered cell wall composition (Ram et al., 1994). Lack of
Cwh8p leads to a deficiency in protein N-glycosylation,
whereby cwh8Δ cells contain only 20% of the normal
amount of dolichylpyrophosphate-linked oligosaccharides
so that many glycoproteins are severely underglycosylated.
Thus, only a fraction of the normally glycosylated Asn-X-
Ser/Thr acceptor sites in carboxypeptidase (CPY) or invertase
are N-glycosylated. The structure of the transferred oli-
gosaccharides is, however, normal (van Berkel et al., 1999).
Cwh8Δ accumulates dolichylpyrophosphate (Dol-PP) and
have recently been shown to lack the Dol-PP phosphatase
activity that converts Dol-PP into dolichylphosphate (Dol-
P) (Fernandez et al., 2001). Cwh8p is an integral membrane
protein with four transmembrane domains having a
lumenally oriented active site (Fernandez et al., 2001).
Indeed, Dol-PP is generated in the endoplasmic reticulum
(ER) lumen by oligosaccharyltransferase (OST) that trans-
fers oligosaccharides from Dol-PP onto nascent and newly
made glycoproteins in the ER. To explain the underglyco-
sylation phenotype of the cwh8Δ mutants the Dol cycle
model has been proposed. The Dol cycle model assumes
that the lumenally generated Dol-PP has to be dephospho-
rylated to Dol-P before being back transported to the cyto-
solic leaflet, a process through which Dol-P would regain
the ability to serve as an acceptor for the cytosolic glycosyl-
transferases. The cytosolic glycosyltransferases use Dol-P
and sugar-nucleotides to generate Dol-P-Man, Dol-P-Glc
as well as Dol-PP-GlcNAc2-Man5, which all are then
flipped to the lumenal leaflet where they serve as donors for
N- and O-glycosylation as well as glycosylphosphatidyl
inositol (GPI) anchor biosynthesis. The flippase for Dol-
PP-GlcNAc2-Man5 has been identified as Rft1p (Helenius
et al., 2002). The Dol cycle model is also supported by the
fact that overexpression of RER2 rescues the growth defect
of cwh8Δ (Sato et al., 1999; Fernandez et al., 2001). RER2
encodes the major cis-prenyltransferase of yeast, the key
enzyme for Dol biosynthesis (Sato et al., 1999). The Dol
cycle model suggests that cwh8 and rer2 mutants are similar
in that both suffer from a relative lack of Dol-P at the cyto-
solic face of the ER membrane to serve as acceptor for
glycosyltransferases. Interestingly, rer2 cells also show an
aberrant proliferation of ER- and Golgi-membranes, and
they fail to retain Sec12p in the ER. These phenomena were
not observed in other mutants causing hypoglycosylation
such as the dolicholkinase mutant sec59. This led to the
speculation that Dol or one of its derivatives in addition to
playing a role in protein glycosylation, may function in
protein retention and organelle homeostasis (Sato et al.,
1999).
While carrying out a brute force screen requiring the met-
abolic labeling of yeast cells with [3H]inositol ([3H]Ins) we
incidentally observed that cwh8Δ cells display a strong
reduction of inositolphosphorylceramides (IPCs) similar to
what was recently found in erg26-1 and arv1Δ mutants
(Swain et al., 2002a,b). Here we investigate the reason for
this abnormality and try to evaluate whether it is a conse-
quence of defects in one or several glycosylation pathways
or if it is a more direct consequence of the perturbation of
the Dol cycle.
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Results
The cwh8Δ mutants show an abnormal profile of 
[3H]Ins-labeled lipids
The biosynthetic pathway for the elaboration of yeast sphin-
golipids is shown in Figure 1. As can be seen in Figure 2A and
as quantified in Figure 2B, the incorporation of [3H]Ins into
IPCs, particularly IPC/C is drastically decreased in cwh8Δ; the
abnormality is observed in different genetic backgrounds, and
transfection of the wild-type (wt) gene restores a normal sphin-
golipid profile (Figure 2A, lanes 3−5). The identity of IPCs
was confirmed by mild base deacylation (data not shown).
Interestingly, the level of inositolphosphoryl-MIPC (M(IP)2C)
is not generally affected, whereas the band comprising IPC/D
and mannosyl-IPC (MIPC) usually is low but sometimes
appears normal. (Our thin-layer chromatography [TLC] sys-
tem resolves IPC/D and MIPC only poorly.)
As shown in Figure 3A, the relative lack of IPC/C can be
observed not only at the end of a 2 h standard labeling period
but is observed throughout the labeling. Even if [3H]Ins-
labeled cells are further incubated for 20 h allowing [3H]Ins to
be chased by endogenously produced cold Ins, a conspicuous
absence of IPC/C, IPC/D, and MIPC in cwh8Δ mutants per-
sists, but M(IP)2C is normal or increased (Figure 3B). [
3H]Ins
was incorporated by cwh8Δ cells as efficiently as by wt cells
although the doubling time of cwh8Δ cells is twice the one of wt.
In vitro IPC synthase and ceramide synthase activities of 
cwh8Δ
Phytosphingosine (PHS) is efficiently taken up by yeast cells
and, when added to the culture medium, fully compensates for
the lack of LCB1, the essential key enzyme for PHS biosyn-
thesis (Figure 1) (Buede et al., 1991). Yet, the addition of
PHS or dihydrosphingosine (DHS) to the medium did not
stimulate the incorporation of [3H]Ins into IPC/C (Figure
4A) in cwh8Δ cells. This suggests that PHS production is
not limiting for IPC/C biosynthesis in cwh8Δ. Moreover, as
can be seen from Figure 4B, and as verified by quantitation
of the various spots, microsomes from cwh8Δ, when incubated
with [3H]DHS and C26-CoA, make normal amounts of
ceramide and at a normal rate. Cwh8Δ derived microsomes
also make rather high amounts of IPCs when incubated
with water soluble short chain [3H]ceramides (Figure 4C).
Finally, IPC synthesis of cwh8Δ cells was also found to be
Fig. 1. Sphingolipid biosynthesis in yeast. DAG, diacylglycerol; MIPC, 
mannosyl-IPC; M(IP)2C, inositolphosphoryl-MIPC; and PI, phosphatidyl 
inositol. Genes are in italics.
Fig. 2. Sphingolipid biosynthesis is defective in the absence of CWH8. (A) 
Strains with cwh8Δ deletions in the BY4742 or SS328 background were 
labeled with [3H]Ins, lipids were extracted, and separated by TLC. Incor-
poration of [3H]Ins into lipids was equally efficient in all strains. In 
lipid extracts stored in chloroform/methanol/water, M(IP)2C becomes 
insoluble over time, especially at −20°C (observation originally made by 
Jens Knudsen; personal communication). This explains the relative low 
abundance of this species in lanes 3–5. (B) Quantitation of results shown 
in panel A by Berthold radioscanning. The total of radioactivity in each 
lane is taken as 100%.
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normal when the incorporation of short chain [3H]ceramides
into IPCs was measured in intact cells (Figure 4D).
Fatty acid elongation, which generates C26:0-CoA, the
preferred substrate of ceramide synthase (Figure 1),
appears to be functioning normally in cwh8Δ as the TLC
mobility of the remaining IPCs and of M(IP)2C is normal
(Figure 2A, lanes 1 and 2).
Thus, we could not detect any deficiency in the enzymes
that are required to make IPC in cwh8Δ.
The cwh8Δ mutants anchor GPI proteins normally
The cessation of the Dol cycle in cwh8Δ ought to cause a
lack of Dol-P and thereby compromise Dol-P-Man biosyn-
thesis at the cytosolic leaflet of the ER. Dol-P-Man is
required for the biosynthesis of N- and O-glycans and of
GPI anchors. A reduction in GPI anchoring by itself would
not be sufficient to cause a depression of IPC synthesis,
because numerous gpi mutants analyzed in our laboratory
showed normal biosynthesis of IPCs (Canivenc-Gansel et al.,
1998; Meyer et al., 2000; Fraering et al., 2001), but a GPI
deficiency could nevertheless be required for the depression
of IPC levels in cwh8Δ cells. To assay the biosynthesis of
GPI lipids in cwh8Δ mutants, microsomes were labeled with
uridine diphosphate (UDP)-[3H]GlcNAc (Figure 5A). A
normal set of GPI lipids was made by cwh8Δ microsomes.
To see whether the GPI lipids are transferred onto GPI
proteins at a normal rate we analyzed the GPI protein
Gas1p, whose ER form migrates at 105 kDa and whose
mature form, produced after arrival in the Golgi, migrates
at 125 kDa by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS–PAGE). As long as a GPI anchor is
not added to Gas1p, the protein is not packaged into
COPII vesicles and not transported to the Golgi so that it
accumulates as an immature 105 kDa form. Indeed, any
significant reduction of GPI lipid biosynthesis leads to an
increase of the immature 105 kDa form of Gas1p (Benghezal
et al., 1995). As can be seen from Figure 5B, the mature
form of Gas1p was present in reduced amounts in cwh8Δ
and was slightly underglycosylated. Tunicamycin (Tm)
pretreatment of wt cells shows that the ER form lacking
N-glycans runs at 83 kDa (lane 3), whereas the absence of
all N- and O-glycans results in a 60 kDa form as seen in
sec59 at 37°C. In cwh8Δ the zone between 105 and 60 kDa
is empty, arguing that there is no accumulation of any imma-
ture ER form, and hence no lag in GPI anchor addition.
Fig. 3. Kinetics of [3H]Ins incorporation in cwh8Δ. (A) Wt (BY4742) and 
cwh8Δ cells were labeled with [3H]Ins for the indicated times. Lipids were 
extracted, separated on TLC, and the cpm in each lipid species was quan-
titated. (B) Cells were labeled with [3H]Ins, and the incubation was contin-
ued for 20 h, allowing the radioactivity to be chased by the endogenously 
made, cold Ins. Lipids were extracted, separated on TLC, and quantified.
Fig. 4. The cwh8Δ cells make DHS, PHS, and ceramide normally. (A) 
Cells were preincubated (10 min) and labeled with [3H]Ins in presence or 
absence of 5 μM DHS or PHS, and lipids were separated on TLC and 
quantitated. (B) Ceramide synthase in vitro. Microsomes were incubated 
with [3H]DHS and C26-CoA for 5–60 min. The amount of C26-DHS made 
as a fraction of the total radioactivity is given below each lane. (C) C2- or 
C4-[
3H]DHS was incubated alone (lanes 1 and 4) or in the presence of 
microsomes (lanes 2, 3, 5, and 6) for 60 min at 30°C to measure 
IPC-synthase activity. Lipids were extracted and separated by TLC. (D) 
Intact cells were incubated with C2-, C4-, or C6-[
3H]DHS for 2 h at 30°C. 
Lipids were extracted and separated by TLC. The amount of the IPC 
made is given as a percentage of total amount of label present in each lane.
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The reduction of mature Gas1p in cwh8Δ was consistently
observed in several experiments, but it does not necessarily
mean that there is a problem with GPI anchoring, because
mutants affecting other Dol-P dependent reactions can lead
to a similar reduction of Gas1p. Thus, as shown in Figure 5B,
Gas1p was found to be reduced in certain pmtΔ double
mutants deficient in O-glycosylation. The dolicholkinase
mutant sec59, which lacks Dol-P at 37°C and has a com-
bined N-glycosylation, O-glycosylation, and GPI anchoring
defect (Heller et al., 1992), shows equally a severe reduction
of Gas1p (Figure 5B). The reduction of Gas1p in cwh8Δ
mutants is not a consequence of reduction of IPC/C because
blocking IPC biosynthesis for 2 h using aureobasidin A (AbA)
(Figure 1) does not reduce Gas1p levels (Figure 5B).
Remodeling of GPI anchor lipids is thought to be oper-
ated by an enzyme that is similar to the IPC-synthase
Aur1p (Reggiori and Conzelmann, 1998). As the loss of
Cwh8p may affect the IPC-synthase, we wondered if this
defect also affects GPI anchor remodeling. For this, we
labeled cwh8Δ cells with [3H]Ins, isolated the lipids of the
GPI anchors and analyzed them by TLC. As can be seen in
Figure 5C, the spectrum of anchor lipids made by the
mutants was normal, the prevalent lipids being IPC/B and a
phosphatidyl inositol (PI) having C26:0 in sn2 causing a
higher Rf than seen in the ordinary PI of cellular mem-
branes (Sipos et al., 1997). Thus, GPI anchor remodeling
seems to proceed normally in cwh8Δ mutants. Also, in the
experiment shown in Figure 5C, the incorporation of
[3H]Ins into proteins was the same for mutant and wt cells,
further demonstrating that cwh8Δ mutants do not have any
problem with GPI anchoring.
Influence of O-glycosylation defects on IPC biosynthesis
Protein O-glycosylation in the ER also uses Dol-P-Man. We
therefore tested whether mutations specifically affecting
O-glycosylation could alter the sphingolipid profile. The pmt
genes encode for ER-localized protein mannosyltransferases
of partially overlapping acceptor specificity (Strahl-Bolsinger
et al., 1999). As summarized in Table I, some cells containing
the pmt1Δ deletion combined with the pmt2Δ or the pmt5Δ
deletion show a moderate decrease of IPC biosynthesis. More-
over, dpm1-6 mutants have a temperature sensitive defect in
Dol-P-Man synthase. At 37°C these cells do not transfer any
O-glycans, are unable to synthesize GPI lipids but transfer
incomplete GlcNAc2-Man5-Glc3 oligosaccharides to proteins
(Orlean, 1990). The dpm1-6 mutant shows only a moderate
decrease of the IPC biosynthesis although it has a significant
difficulty in making IPC/D-MIPC and M(IP)2C (Table I), this
concomitant decrease being unique for this strain.
Hsp150, a secretory protein which carries a high amount
of O-glycans, but no N-glycans, is underglycosylated or
fails to be secreted in pmt1Δ, pmt2Δ, pmt4Δ, and sec59
mutants (Figure 6) (Gentzsch and Tanner, 1997). Removal
of O-glycans using hydrofluoric acid reduces its molecular
mass from 150 to 47 kDa (Russo et al., 1992). Yet, cwh8Δ
makes normally glycosylated Hsp150 with only small
amounts being underglycosylated (Figure 6). Thus, it
would appear that O-glycosylation defects in principle can
slightly depress IPC/C levels but that, in contrast to N-glyc-
osylation, the O-glycosylation is not affected in cwh8Δ
mutants and that an O-glycosylation defect therefore can-
not explain the deficiency in IPC/C of cwh8Δ mutants.
Influence of the N-glycosylation defects on IPC biosynthesis
Treatment of wt cells with the N-glycosylation inhibitor Tm,
which specifically inhibits the transfer of GlcNAc-P onto
Dol-P, induces a drastic decrease of [3H]Ins incorporation into
Fig. 5. The cwh8Δ cells add GPI anchors normally. (A) Microsomes were 
labeled with UDP-[3H]GlcNAc in the presence of GDP-mannose. Lipids 
were extracted and migrated on a TLC. CP, complete precursor. (B) Pro-
teins were extracted from the indicated strains and processed for western 
blotting. Blots were probed with anti-Gas1p. AbA was added at 1 μg/mL 
for 2 h, and sec59 cells were grown for 4 h at 37°C before extraction. The 
immature (i) and mature (m) forms of Gas1p are indicated. (C) Cells were 
labeled with [3H]Ins at 30°C for 2 h, GPI anchored proteins were isolated, 
anchor peptides were prepared, and their lipid moieties released by HNO2 
treatment as described (Guillas et al., 2000). The liberated anchor lipids 
were analyzed by TLC. The lipid extract of the labeled BY4742 cells 
served as standard (lane 1).
Table I. O-Glycosylation mutants
Strain PI + LysoPI IPC/C IPC/D + MIPC M(IP)2C
SEY6210 48.0 15.7 24.1 10.6
SEY6211 24.7 29.1 27.1 17.5
pmt1Δ pmt2Δ 36.8 10.5 44.5 6.2
pmt1Δ pmt3Δ 29 23.1 26.9 18.5
pmt1Δ pmt5Δ 57 11.2 19.1 11.4
pmt2Δ pmt4Δ 28.8 35.1 20.7 14.1
dpm1-6, 24°C 39.2 29.2 20.6 9.9
dpm1-6, 37°C 60.8 21.9 8.2 5
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IPC (Figure 7A and B). Cells incorporated [3H]Ins effi-
ciently into M(IP)2C, and this was true even after pro-
longed preincubation in 10 μg/mL of Tm or when the
labeling was extended to 20 h allowing the label to be
chased by the endogenous Ins production. Thus, inhibition
of N-glycosylation using Tm seems to faithfully mimic the
sphingolipid abnormality of cwh8Δ mutants (Figure 7C).
To evaluate if a particular structural feature of N-glycans
had an impact on IPC/C levels, we tested a series of N-glyc-
osylation mutants. Strains deleted for ALG3, ALG6, ALG8,
and ALG9, which cannot add all mannoses and glucoses to
Dol-PP-GlcNAc2-Man5 in the lumen of the ER, did not
present any defect of sphingolipid biosynthesis (Table II).
The truncated oligosaccharides added in these mutants can
still get elongated in the Golgi, whereby the molecular mass
of glycoproteins can be massively increased. Therefore we
also tested och1Δ, a mutant in which elongation of N-glycans
is completely abolished (Nakanishi-Shindo et al., 1993).
The och1Δ cells made normal amounts of IPC but showed a
moderate reduction of IPC/D-MIPC and a compensatory
increase of M(IP)2C (Table II). IPC levels were, however,
depressed in certain mutants having defects in the OST
such as the ost5Δ alg5Δ and in also cells depleted of Rft1p
but not in others such as ost3Δ ost6Δ (Figure S1; Table II).
Analysis of the N-glycosylation status of CPY showed
that the mutants having decreased IPC/C levels also had
severe underglycosylation of CPY (Figure 7D). Thus, it
appears that a defect of IPC synthesis is not correlated with
the absence of some particular structural feature of the
N-glycan core, but rather maybe the consequence of severe
N-underglycosylation. The correlation also holds in rer2-2,
a mutant that has been reported to have a severe
hypoglycosylation phenotype affecting not only N- but
also O-glycosylation and GPI anchoring (Sato et al., 1999).
As shown in Table II and Figure 7D, the rer2-2 strain
exhibited only a moderate decrease of IPC-C levels, but CPY
also was less severely underglycosylated than in cwh8Δ.
The effects of the unfolded protein response on the 
sphingolipid profile
Underglycosylation and Tm treatment induce an unfolded
protein response (UPR) (Travers et al., 2000). Using a plasmid
carrying an UPR responsive element (UPRE) in the pro-
moter in front of lacZ we found that the UPR was indeed
constitutively activated in cwh8Δ (data not shown). Also,
secretion of Kar2p, an ER chaperone, has been recognized
as a sign of UPR activation. As shown in Figure 8A, cwh8Δ
cells secrete significant amounts of Kar2p, significantly
more than what is secreted by wt cells exposed to Tm or
AbA. The UPR strongly induces the transcription of INO1,
the rate limiting enzyme for Ins and PI biosynthesis in yeast
(Figure 1) (Cox et al., 1997). We indeed observed that
cwh8Δ overproduce and secrete Ins, that is, that they dis-
play the so called opi phenotype (Figure S2). We wondered
if the decreased incorporation of [3H]Ins into IPC/C in
cwh8Δ mutants and Tm-treated cells could be explained by
an increase in Ins and PI biosynthesis, so that cwh8Δ cells,
when labeled with [3H]Ins, would make PI and IPC/C of
lower specific activity than wt but in normal amounts. This
hypothesis seemed unlikely because cwh8Δ cells incorporate
normal amounts of [3H]Ins into M(IP)2C (Figures 2A and 3).
Fig. 6. Cwh8Δ cells O-glycosylate proteins normally. Cells were grown at 
30°C or the indicated temperatures, and cell lysates were analyzed by 
western blotting using antibodies against Hsp150 (Pir2p).
Fig. 7. Tm causes a reduction in IPC/C levels. (A) Cells were preincubated 
for 2 h in SDaaUA with or without Tm (2.5 μg/mL) and labeled with 
[3H]Ins. (B) Quantification of lipids in panel A. (C) Cells were labeled with 
[3H]Ins during 2 or 20 h after preincubations of 0, 2, or 15 h in presence of 
Tm; labeled lipids were analyzed by TLC. Total incorporation into lipids 
is given for each condition (μCi). (D) CPY western blot analysis. Proteins 
were extracted from cells having been exposed to Tm (10 μg/mL) for 2 h, 
doxycyclin (150 μg/mL) for 15 h, or elevated temeprature (37°C) for 2 h. 
The completely deglycosylated mature form of CPY has a peptide mass of 
47.4 kDa; smaller fragments are presumably degradation products.
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It was further rendered unlikely by experiments, in which
cold Ins (up to 50 mg/L) was added to the labeling medium.
Addition of cold Ins did not significantly change the frac-
tion of [3H]Ins incorporated into sphingolipids (Figure S3).
Furthermore, the relative lack of IPC/C could also be seen,
when the sphingolipids of cwh8Δ cells were revealed by
charring (Figure 8B). Finally, we tested other mutants dis-
playing a strong opi phenotype such as sec14 (Henry and
Patton-Vogt, 1998), or cells in which the UPR is constitu-
tively induced by the presence of HAC1-i, a spliced, that is,
active version of the HAC1 transcription factor. Neither
one of these cells showed a decreased IPC/C biosynthesis
(Table III).
Treatment with Tm or deletion of CWH8 leads to an
accumulation of underglycosylated proteins, which invari-
ably induce an UPR. To test if the UPR, although not suffi-
cient, is required to provoke reduced IPC biosynthesis
under Tm treatment, we tested if Tm can induce the reduc-
tion of IPC in ire1Δ cells which are unable to induce an
UPR (Sidrauski and Walter, 1997). As shown in Figure 8C,
IPC/C biosynthesis is still Tm sensitive in ire1Δ cells.
Thus, it seems that the altered sphingolipid profile of the
cwh8Δ mutant is not a consequence of its constitutive UPR
or its increased biosynthesis of Ins but is caused solely by
the N-underglycosylation and that the associated UPR
response is not required for the appearance of the abnormal
sphingolipid profile.
Isc1p, an IPC hydrolase may, if mislocalized, selectively
destroy IPC (Sawai et al., 2000). However, Tm causes the
characteristic drop in IPC/C and IPC/D-MIPC labeling also
in isc1Δ cells (data not shown). This argues that Isc1p is not
involved in the depression of IPC levels when N-glycosylation
is repressed.
Quantification of Aur1p in cwh8Δ mutants
Aur1p is an integral membrane protein with seven membrane
spanning domains and three potential N-glycosylation sites,
two of which are predicted to be lumenally exposed by the pro-
gram displayed at http://www.cbs.dtu.dk/services/TMHMM/.
The cwh8Δ mutants were crossed with TLY139, a strain, in
which the genomic AUR1 gene had been tagged with an
hemagglutinin antigen (HA) tag. As shown in Figure 9A,
spore 8A (cwh8Δ) contains as much Aur1p-HA as spore 8C
(CWH8), and the Aur1p does not seem to be underglycosy-
lated in the cwh8Δ background, suggesting that none of its
Table II. N-Glycosylation mutants
Strain PI + LysoPI IPC/C IPC/D + MIPC M(IP)2C
BY4742 13.1 34.5 31.7 19.3
cwh8Δ 60.6 4.1 5.3 28.1
alg3Δ 44.1 19.8 21.1 14.0
alg6Δ 45.8 19.6 23.1 10.7
alg8Δ 47.9 15.4 22.7 13.2
alg9Δ 44.4 19.6 25.2 10.0
och1Δ 23.7 32.5 15.2 27.9
R1158 24.5 28.9 31.7 11.3
Tetrft1 49.7 9.2 6.6 33.1
SS328 23.6 26.0 34.4 13.5
ost5Δ alg5Δ 80.2 2.4 5.2 11.2
ost3Δ ost6Δ 23.7 20.1 31.5 23.4
SNY9 26.7 25.2 30.7 16.0
rer2-2, 24°C 42.3 17.0 30.7 7.9
rer2-2, 37°C 33.2 18.6 40.7 5.8
Fig. 8. The abnormal sphingolipid profile of cwh8Δ is not caused by its 
UPR. (A) Strains were inoculated at 0.5 OD600, cultured for 1 or 3 h at 
30°C, and media were collected, trichloroacetic acid (TCA) precipitated, 
and processed for western blot detection of Kar2p, a 70-kDa protein. (B) 
Lipids were extracted from unlabeled cells, deacylated, and 25 OD600/
strain were separated by TLC. Lipids were detected by charring. Control 
experiments showed that the admixture of the same amount of cold lipids 
to [3H]Ins-labeled lipids leads to the disappearance (precipitation) of M(IP)2C 
(data not shown). (C) Aliquots of ire1Δ were labeled with 10 μCi of [3H]Ins 
using different preincubation times, labeling times, and concentrations of Tm. 
Total incorporation into lipids is given for each condition (μCi).
Table III. Influence of UPR and secretion blocks on IPC/C level
aThree different sec7 strains.
Strain PI + LysoPI IPC/C IPC/D + MIPC M(IP)2C
BY4742 56.6 11.0 8.4 22.7
cwh8Δ 79.6 1.8 1.7 15.2
SS328 43.8 22.6 26.6 5.9
SS328 + pHAC-i 30.8 23.2 36.9 8.0
sec14, 24°C 50.5 12.0 8.9 27.3
sec14, 37°C 38.8 21.5 26.0 10.8
sec7,a 24°C 25.5 19.5 29.8 24.4
sec7,a 37°C 30.9 38.2 13.3 16.6
sec7,a 24°C 32.8 30.9 19.9 15.7
sec7,a 37°C 40.6 39.3 8.7 9.4
sec7,a 24°C 45.2 28.0 18.0 8.0
sec7,a 37°C 34.4 39.4 9.7 15.3
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three potential N-glycosylation sites is used. Also, the
apparent molecular weight of Aur1p-HA was unchanged,
when TLY139 (AUR1-HA) cells were grown in Tm (data
not shown). The spore 8A (cwh8Δ AUR1-HA) showed the
expected defect in IPC biosynthesis (Figure 9B). We thus
conclude that the relative lack of IPC biosynthesis in cwh8Δ
mutants cannot be explained by a loss or by underglycosy-
lation of Aur1p.
The cwh8Δ cells accumulate internal membranes. Elec-
tron microscopy pictures of rer2 cells, being deficient in
cytosolic Dol-P as cwh8Δ cells, show an aberrant prolifera-
tion of ER and Golgi membranes (Sato et al., 1999). Elec-
tron microscopy of cwh8Δ cells typically shows
fragmentation of vacuoles and a discrete proliferation of
internal membranes that has ER-like morphology (Figure S4).
Vacuolar fragmentation is equally seen using FM4-64, a
compound that stains vacuolar membranes (data not
shown). This is somewhat in contrast to the morphological
classification of cwh8Δ as class C vps mutant (Bonangelino
et al., 2002), as the presence of fragmented vacuoles would
place them rather into the vps mutant class B (Raymond
et al., 1992). The accumulation of internal membranes is
reminiscent of what was described for rer2-2 mutants. In
our hands the accumulation of membranes in rer2-2 was
not more pronounced than what was observed in cwh8Δ (data
not shown).
General properties of cwh8Δ mutants
For many sphingolipid biosynthesis mutants the concentra-
tions of Ca2+ and Zn2+ in the medium are critical, but
growth of cwh8Δ mutants was not influenced by the presence
of these cations in the medium (data not shown). Also, they
are respiration competent.
Discussion
In S. cerevisiae, the main sphingolipids are IPC, MIPC, and
M(IP)2C and represent major components of the plasma
membrane (Dickson and Lester, 1999). Aur1p, the IPC syn-
thase is essential, whereas the later acting genes required for
making MIPC and M(IP)2C have been shown to be dis-
pensable (Lisman et al., 2003). Mutations in ergosterol bio-
synthesis have been shown to alter sphingolipid
biosynthesis in two recent reports: One report demonstrates
that erg26-1 mutants specifically decrease IPC and MIPC,
whereas M(IP)2C remains normal (Swain et al., 2002a);
another report shows that cells lacking Arv1p, a multispan-
ning integral membrane protein required for sterol uptake
and intracellular sterol distribution, greatly reduce the bio-
synthesis of all IPCs including M(IP)2C (Swain et al.,
2002b). It is presently unknown, by what mechanism the
ergosterol and sphingolipid biosynthesis pathways influ-
ence each other.
Here we examined cwh8Δ mutants which show a sphin-
golipid profile similar to the one of erg26-1 cells because we
find IPCs to be reduced, whereas M(IP)2C levels are nor-
mal. Our data on cwh8Δ indicate that the flux through the
pathway leading to the synthesis of M(IP)2C is normal but
that intermediates IPC/C and often IPC/D-MIPC are
strongly reduced. The cwh8Δ cells contain normal amounts
of ergosterol and of the biosynthetic intermediates of the
ergosterol pathway (Claude Jakob et al., personal commu-
nication) so that the abnormality of its sphingolipid profile
cannot be attributed to a deficiency in ergosterol biosynthe-
sis. Rather the abnormal sphingolipid profile seems to be
caused by a defect in N-glycosylation.
Indeed the lack of CWH8 seems to affect mainly the
N-glycosylation pathway, whereas O-gylcosylation and GPI
anchoring are not or only slightly affected (Figures 5 and 6;
Table I). As pointed out before, the N-underglycosylation
could be due to either a relative lack of Dol-P at the cytoso-
lic side of the ER membrane or an inhibitory effect of the
accumulated Dol-PP (Fernandez et al., 2001). However, the
profile of Dol-linked oligosaccharides of cwh8Δ (van Berkel
et al., 1999) suggests that there is no inhibiton of the lume-
nal glycosylation reactions transforming Dol-PP-GlcNAc2-
Man5 into Dol-PP-GlcNAc2-Man9-Glc3 and of the OST.
This finding suggests that cwh8Δ suffers from a relative lack
of cytosolic Dol-P than Dol-PP accumulation. The lack of
cytosolic Dol-P of cwh8Δ cells is predicted by the so called
Dol cycle model. Our calculations (Table SI) indicate that
indeed the content of Dol in ER membranes is by far insuf-
ficient to support all the manifold glycosylation reactions
that occur unless Dol can be recycled. Most importantly,
the finding that Tm treatment and certain ost or rft1
mutants faithfully reproduce the abnormal sphingolipid
profile of cwh8Δ cells clearly indicates that the lack of Dol-P
or the accumulation of Dol-PP do not affect sphingolipid
biosynthesis directly, but they do so through the ensuing
N-underglycosylation.
Fig. 9. Aur1p expression is normal in cwh8Δ. (A) TLY139, a wt strain 
containing a HA-tagged version of Aur1p was crossed with cwh8Δ, and a 
tetrad obtained from the diploid was analyzed by western blotting with 
antibodies against the HA tag and CPY. Aur1p-HA is a 45-kDa protein. 
Underglycosylation of CPY in spores A and B indicates the presence of 
the cwh8::KanMX allele. (B) Cells were labeled with [3H]Ins, and lipids 
were quantified by TLC.
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If a relative lack of cytosolic Dol-P of cwh8Δ cells can
affect only N- but no other glycosylation reactions, we also
have to assume that the various pathways that depend on
cytosolic Dol-P have different affinities for, or different
accessibility to Dol-P. Even though only Dol-PP-GlcNAc
synthesis is affected in cwh8Δ, the total amount of Dol-P
required is significantly reduced in this mutant as each Dol-
PP-GlcNAc that is not made spares the system the need of
making further 4 Dol-P-Man and 3 Dol-P-Glc.
By what mechanism does N-underglycosylation depress
IPC/C levels? For the moment we speculate that severe
underglycosylation leads either to some perturbation of the
distribution of the sphingolipid biosynthetic enzymes, or to a
size reduction of some biosynthetic compartment (“compart-
ment size hypothesis”), or to the fusion of some normally dis-
tinct compartments (“compartment fusion hypothesis”).
Protein mislocalization may occur in cwh8Δ cells as they
have a similar problem as the Dol biosynthesis mutant rer2.
The rer2 cells contain only 25% of normal levels of Dol and
show defects in N- and O-glycosylation as well as in GPI
biosynthesis (Sato et al., 1999). They mislocalize several ER
components such as Sec12p, Sec71p, and Sec63p to later
secretory compartments but the distribution of Golgi pro-
teins in rer2 cells has not been investigated. Hence, the
defect in sphingolipid biosynthesis of cwh8Δ cells may be
due to mislocalization of some essential component of IPC
biosynthesis to a late Golgi compartment.
The potential validity of the “compartment fusion
hypothesis” is underscored by the observation that brefel-
din A drastically reduces the IPC and MIPC biosynthesis
without affecting biosynthesis of M(IP)2C (Hechtberger
and Daum, 1995). The result may be interpreted as to mean
that the relocalization of Aur1p, Csg1p, Csh1p, and the
M(IP)2C-synthase Ipt1p (Figure 1) from the Golgi into the
ER under brefeldin A, while reducing the overall activity of
these enzymes, will allow whatever product is made to get
immediate access to all enzymes in the pathway, thus allow-
ing for the disappearance of intermediates in face of a
slightly enhanced synthesis of M(IP)2C. The analysis of the
relative abundance of IPC/C and MIPC in the secretion
mutants sec7 and sec14 equally argues that the sphingolipid
biosynthesis in the yeast Golgi is compartmentalized.
Although not pointed out, the data in two earlier reports
(Puoti et al., 1991; Hechtberger et al., 1994) clearly indicate
that IPC and MIPC synthesis may reside in different Golgi
compartments: sec7 mutants (blocking early in the Golgi)
accumulate IPC but make relatively little MIPC, whereas
sec14 mutants (blocking exit from late Golgi) accumulate
high amounts of both. These experiments were reproduced
and quantitated in this study (Table III). The data clearly
suggest that Aur1p can act in an earlier Golgi compartment
than the mannosyltransferases Csg1p and Csh1p. This may
seem to be in contradiction with a recent report showing
that the immunoisolation of Aur1p-HA-containing
microsomes brings down the same fraction of total Csg1p
as of total Aur1p, suggesting that these two proteins reside
in the same compartment (Lisman et al., 2003). Yet, this
result does not exclude the existence of a compartment con-
taining only Aur1p but no Csg1p, and the immunofluores-
cence studies reported in the same paper show only partial
overlap between Csg1p and Aur1p (Lisman et al., 2003).
Under the assumption that Aur1p, Csg1p, and maybe Ipt1p
(Figure 1) reside in different compartments, the level of IPC
and MIPC present in a given cell may be a reflection of the
relative size of the early and mid Golgi compartment. It
seems conceivable that the drastic reduction of Golgi-based
N-glycan elongation in cwh8Δ mutants may lead to a size
reduction of the Aur1p+/Ipt1p− Golgi compartment and
thus reduce the time during which IPC/C stays in that com-
partment. To test this “compartment size hypothesis” we
tried to see whether other changes in Golgi morphology
would change the relative amounts of IPC. For this we used
cells overexpressing Vig4p, the GDP-mannose transporter
of the Golgi because overexpression of this gene has been
shown to lead to the appearance of very massive Golgi-like
structures in yeast (Hashimoto et al., 2002). However, over-
expression of VIG4 did not increase the relative amount of
IPC or MIPC as compared to the total amount of sphin-
golipids (data not shown). Studies to test the “compartment
fusion hypothesis” are ongoing.
In summary, this and other recent studies reveal that,
beyond the genes that directly are involved in the biosyn-
thesis of yeast sphingolipids such as ELO2, AUR1, CSG1,
CSH1, and IPT1, sphingolipid biosynthesis is indirectly
affected by alterations in sterol biosynthesis, N-glycosylation,
and vesicle traffic, although further efforts are required to
unravel the mechanisms by which this occurs.
Materials and methods
Materials
Cells were grown at 30°C in rich medium yeast extract pep-
tone dextrose (YPD) or minimal media (e.g., salt dextrose)
containing salts (S), 2% glucose (D) as a carbon source,
uracil (U), adenine (A), and amino acids or casein hydroly-
sate (C) as described (Sherman, 2002). Wt strains were
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0; SS328 MATα
ade2-101 ura3-52 his3-Δ200 lys2-801; SEY6210 MATα ura3-
52 leu2-3,112 his3-Δ200 lys2-801 trp1-Δ901 suc2-Δ9; SEY6211
MATα ura3-52 leu2-3,112 his3-Δ200 ade2-101 trp1-Δ901
suc2-Δ9; and R1158 MATα ura3::CMV-tTA his3-1 leu2Δ0
met15Δ0. Mutant strains were cwh8Δ-1 YGR036c::kanMX4
in BY4742; cwh8Δ-2 YGR036c::HIS3 in SS328; dpm1 MATα
dpm1-6 ura3; SNH023-7D MATα rer2-2 mfα1::ADE2
mfa2::TRP1 bar1::HIS3 ura3 trp1 leu2 his3 ade2 lys2;
HMSF169 MATa sec14-3; alg3Δ YBL082c::kanMX4 in
BY4742; alg6Δ YOR002w::kanMX4 in BY4742; alg8Δ
YOR067c::kanMX4 in BY4742; alg9Δ YNL219c::kanMX4
in BY4742; ost5Δ alg5Δ ost5::HIS3 alg5::HIS3 in SS328;
RKY327 ost3Δost6Δ MATα ade2-101 ura3-52 his3Δ200
ost3::HIS3 ost6Δ; pmt1Δ pmt2Δ pmt1::URA3 pmt2::LEU2
in SEY6210; pmt1Δ pmt3Δ pmt1::URA3 pmt3::HIS3 in
SEY6210; pmt1Δ pmt5Δ pmt1::HIS3 pmt5::URA3 in SEY6210;
pmt2Δ pmt4Δ pmt2::URA3 pmt4::TRP1; Tetrft1 pRFT1::kanR-
tet07-TATA URA3::CMV-tTA; ire1Δ YHR079c::kanMX4 in
BY4742; TLY139 aur1::AUR1-3XHA-HIS5(S.p) in SEY6210;
FBY337 YGR036c::kanMX4 aur1::AUR1-3XHA-HIS5(S.p)
his3 leu2 ura3; och1Δ YGL038c::kanMX4 in BY4742;
NY758 sec7-1; NY878 MATa sec7 ura3 leu2; and NY966
MATa sec7-1 ura3 leu2 his3. Plasmids pCWH8, pMPG1,
pSV463VIG4, and pRC43 contain CWH8, MPG1,
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VIG4, and HAC1-i (spliced, constitutively active HAC1),
respectively.
All chemicals were from commercial suppliers. Tm was
from Fluka (Buchs, Switzerland). Antibody against Hsp150p
was kindly provided by Marja Makarow (Helsinki, Fin-
land), antibodies against Kar2p were a gift from Dr. Marc
Rose, and antibodies against CPY and the HA tag were
from Molecular Probes (Eugene, OR).
Metabolic labeling of cells with [3H]Ins
Cells growing in YPDUA were labeled in SDamino acids
UA at 30°C during 2 h. To 2.5 OD600 units of cells in 250
μL of medium, preincubated for 10 min, 4 μCi [3H]Ins per
OD600 unit were added. After 40 min, the culture was
diluted with 750 μL of fresh medium and further incubated.
The labeling was stopped by the addition of trichloroacetic
acid (TCA) to a final concentration of 5%. After 5 min on
ice, the cells were centrifuged and washed twice with 1 mL
of water. Lipids were extracted twice using 500 μL of EtOH
: H2O : Et2O : pyridine : 25% NH4OH, 15:15:5:1:0.018 for
20 min at 60°C. Lipids were desalted by butanol/water parti-
tioning and stored at −20°C. In lipid extracts stored in chlo-
roform/methanol/water, M(IP)2C becomes insoluble over
time, especially at −20°C (Jens Knudsen, personal commu-
nication). This explains the relative low abundance of this
species in certain experiments.
Microsomal assays
Microsomes were prepared and labeled with UDP-
[3H]GlcNAc as described (Canivenc-Gansel et al., 1998).
Lipids were reextracted with 500 μL CHCl3 : MeOH : H2O,
10:10:3.
Lipid analysis
Lipids were separated by TLC on silica gel 60 plates devel-
oped in CHCl3 : MeOH : H2O, 10:10:3, or CHCl3 : MeOH :
KCl 0.25%, 55:45:5, or CHCl3 : MeOH : KCl 0.25%,
55:45:10. Plates were read with a Berthold radioscanner
and then sprayed with EN3HANCE and laid on X-Omat
film (Kodak, Renens, Switzerland) for autoradiography.
Desalted lipids were deacylated in 500 μL of 33% monome-
thylamine (MMA) at 53°C for 2 h. Lipids were detected by
charring as described (Haak et al., 1997).
Assay of ceramide synthase and IPC synthase
Ceramide synthase and IPC synthase activities were assayed
in 100 μL Tris-buffer, pH 7.5 supplemented with 1 mM of
each, ATP, GTP, CTP, GDPMan, CoA, 10 mg/mL creat-
ine phosphate, 10 μg/mL creatine kinase, 300 μM C26-CoA
(in Zwittergent), and 10 μCi of [3H]DHS, C2-[3H]DHS, C4-
[3H]DHS, or C6-[
3H]DHS at 37°C for 1 h. Products were
separated on TLC with CHCl3 : MeOH : 2 M NH4OH,
40:10:1 (ceramide synthase) or with CHCl3 : MeOH : KCl
(0.25%), 55:45:10 (IPC synthase).
Western blotting
Washed cells were extracted as described (Kushnirov,
2000). Proteins were separated under reducing conditions
by SDS–PAGE, transferred to polyvinylidene fluoride
(PVDF) membranes, and detected with enhanced chemilu-
minescence technology (Amersham Biosciences, Bucking-
hamshire, UK).
Supplementary data
Supplementary data are available at Glycobiology online
(http://glycob.oxfordjournals.org/).
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